HC Wainwright & Co. Downgrades HeartBeam to Neutral
Heartbeam Inc BEAT
$0.37
▼ -1.37%
($-0.01)
Open
$0.39
Prev Close
$0.37
Day Range
$0.36 – $0.39
52W Range
$0.36 – $4.00
Market Cap
$20.73M
Beta
-0.72
EPS (TTM)
$-0.51
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-10-14 |
| Shares Out. | 55,510,000 |
| Website | heartbeam.com/ ↗ |
| Phone | 14088994443 |
| Employees | 16 |
| Revenue | $0 |
| Gross Profit | $0 |
| Net Income | -$5.0M |
| Free Cash Flow | -$14.0M |
| Total Assets | $10.6M |
| Total Liabilities | $2.5M |
| Equity | $8.2M |
About Heartbeam Inc
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.
Heartbeam Inc is a publicly traded company under the ticker symbol BEAT on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
9 analysts (2026-09-01)